Skip to main content
Premium Trial:

Request an Annual Quote

Thrive: David Daly

Thrive has appointed David Daly as CEO and to its board of directors. Daly joins the firm with more than 25 years of leadership. Prior to Thrive, Daly served as senior VP and general manager of commercial operations at Illumina. Prior to Illumina, Daly served as general manager and chief commercial officer at Foundation Medicine. Before working at Foundation Medicine, Daly led the oncology business unit at Life Technologies, served as CCO at Clarient, and held roles at Roche Diagnostics and Abbott Laboratories.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.